Journal: American Journal of Medicine Open

Article Title: Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes

doi: 10.1016/j.ajmo.2022.100008

Figure Lengend Snippet: Cohort 1: T1D Population. IBM MarketScan Research Databases, 2017-2019.

Article Snippet: We compared clinical outcomes after acquiring a FreeStyle Libre© Flash Continuous Glucose Monitoring System (FSL) or Dexcom (DEX) continuous glucose monitoring (CGM) device in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) treated with intensive insulin therapy.

Techniques:

Journal: American Journal of Medicine Open

Article Title: Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes

doi: 10.1016/j.ajmo.2022.100008

Figure Lengend Snippet: Cohort 1: T2D participants. IBM MarketScan Research Databases, 2017-2019.

Article Snippet: We compared clinical outcomes after acquiring a FreeStyle Libre© Flash Continuous Glucose Monitoring System (FSL) or Dexcom (DEX) continuous glucose monitoring (CGM) device in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) treated with intensive insulin therapy.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: International Funding of Continuous Glucose Monitoring

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Diagnostic Assay

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Summary of Findings

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Battery

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Sensitivity Analyses for Continuous Glucose Monitoring Model

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Government Expenses for the $920 Annual Grant to Purchase of Blood Glucose Test Strips Through the Ontario Monitoring for Health Program

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring When Insulin Pump, Insulin, and Supplies Are Publicly Funded

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs (All Direct Medical Costs) of Continuous Glucose Monitoring in Ontario

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring when Insulin Pump, Insulin, and 75% of Sensor Costs Are Publicly Funded

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Costs of Continuous Glucose Monitoring Devices With Cost-Reduction Scenarios

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Reference Case, Conservative Projection of a 20% Annual Increase a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Funding for Insulin, Pump, Strips, and 75% of Sensor Costs

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Scenario 2, Conservative Projection of a 20% Annual Increase a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Scenario 2, Entire Type 1 Diabetes Population a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Scenario 2, Population With Hypoglycemia Unawareness Using a Conservative Projection a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Cost Reductions for Continuous Glucose Monitoring Devices

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Continuous Glucose Monitoring Device Cost Reduction Scenarios

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 3, Conservative Projection of a 20% Annual Increase, Device Cost Reduction by 30%, 20%, and 10%

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 3, Entire Type 1 Diabetes Population, Device Cost Reduction by 30%, 20%, and 10%

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 4, Device Cost Reduction by 30%, 20%, and 10%, Plus Government Funding a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 5, Manufacturer's Scenario With an Annual Increase in Adoption of 40%

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 5, Manufacturer's Scenario With an Annual Increase in CGM Adoption of 40%, Entire Type 1 Diabetes Population and Population With Hypoglycemia Unawareness

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Government Expenses for the $170 Annual Grant to Purchase Needles and Syringes for People With Type 1 Diabetes Age 65 Years and Older in Ontario

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Risk of Bias Among Randomized Controlled Trials for Comparison of Continuous Glucose Monitoring and Usual Care a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Comparison

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Risk of Bias Among Observational Studies for Comparison of Continuous Glucose Monitoring and Usual Care a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Comparison

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet:

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Control

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet:

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Control

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: GRADE Evidence Profile for Comparison of Continuous Glucose Monitoring and Usual Care

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: Comparison

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Assessment of the Cost-Effectiveness of Continuous Glucose Monitoring

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Reference Case, Entire Population With Hypoglycemia Unawareness a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Reference Case, Entire Type 1 Diabetes Population a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Scenario 2, Entire Population With Hypoglycemia Unawareness a

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 3, Entire Population With Hypoglycemia Unawareness, Device Cost Reduction by 30%, 20%, and 10%

Article Snippet: 13 , 14 United States Some private insurance companies b Details differ depending on insurance company Medicare Funding for therapeutic continuous glucose monitoring devices Open in a separate window a Information was gathered in part from Dexcom (San Diego, California). b Blue Cross/Blue Shield, Aetna, Cigna, Humana, United Healthcare, Kaiser Permanente, Wellpoint.

Techniques: